Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects
Conditions: Drug Drug Interaction Interventions: Drug: Fluvoxamine; Drug: Itraconazole; Drug: Paroxetine; Drug: ASN51 Sponsors: Asceneuron S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials

Paroxetine Safety and Efficacy in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: Methotrexate; Drug: Paroxetine Sponsors: Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials

The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Paroxetine; Drug: Placebo Sponsors: aya ramadan ashmawy sarhan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials

Concentration-QT Study of Paroxetine in Healthy Adults
Conditions: Anxiety Disorders Interventions: Drug: Paroxetine Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Condition:   Hot Flashes Interventions:   Drug: Fezolinetant;   Drug: Paroxetine;   Drug: Citalopram;   Drug: Escitalopram;   Drug: Desvenlafaxine;   Drug: Venlafaxine;   Drug: Gabapentin;   Drug: Clonidine;   Drug: Pregabalin;   Drug: Oxybutynin;   Drug: Any other SSRI/SNRI not already specified;   Drug: Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above Sponsor:   Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Conditions: Hot Flashes Interventions: Drug: Fezolinetant; Drug: Paroxetine; Drug: Citalopram; Drug: Escitalopram; Drug: Desvenlafaxine; Drug: Venlafaxine; Drug: Gabapentin; Drug: Clonidine; Drug: Pregabalin; Drug: Oxybutynin; Drug: Any other SSRI/SNRI not already specified; Drug: Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above Sponsors: Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults
Condition:   Healthy Interventions:   Drug: DA-8010 5mg;   Drug: Paroxetine 20mg;   Drug: Mirabegron 50mg Sponsor:   Dong-A ST Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials